Skip to main content
Have a personal or library account? Click to login
Hyaluronan and synovial joint: function, distribution and healing Cover

Hyaluronan and synovial joint: function, distribution and healing

Interdisciplinary Toxicology
Volume 6 (2013): Issue 3 (September 2013)
By:   
Open Access
|Feb 2014
References

References

  1. Abeydeera LR. (2002).production of embryos in swine.: 257-273.
    Search in Google Scholar
  2. Adams ME. (1993). Viseosupplementation: A treatment for osteoarthritis.: Suppl. 39: 1-24.
    Search in Google Scholar
  3. Altman RD. (2000). Intra-articular sodium hyaluronate in osteoarthritis of the knee.: 11-18.
    Search in Google Scholar
  4. Aruoma OI, Halliwell B, Hoey BM, Butler J. (1989). The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.: 593.
    Search in Google Scholar
  5. Ashhurst DE, Bland YS, Levick JR. (1991). An immunohistochemical study of the collagens of rabbit synovial interstitium.: 1669-1672.
    Search in Google Scholar
  6. Athanasou NA, Quinn J. (1991). Immunocytochemical analysis of human synovial lining cells: phenotypic relation to other marrow derived cells.: 311-315.
    Search in Google Scholar
  7. Balazs EA, Denlinger JL. (1989). Clinical uses of hyaluronan.: 265-280.
    Search in Google Scholar
  8. Balazs EA, Laurent TC, Jeanloz RW. (1986). Nomencla ture of hyaluronic acid.: 903.
    Search in Google Scholar
  9. Balazs EA. (2003). Analgesic eff ect of elastoviscous hyaluronan solutions and the treatment of arthritic pain.: 49-62.
    Search in Google Scholar
  10. Balazs EA, Denlinger JL. (1993). Viscosupplementation: a new concept in the treatment of osteoarthritis.: 3-9.
    Search in Google Scholar
  11. Banasova M, Valachova K, Juranek I, Soltes L. (2012). Eff ect of thiol compounds on oxidative degradation of high molar hyaluronan.(Suppl. 1): 25-26.
    Search in Google Scholar
  12. Banasova M, Valachova K, Juranek I, Soltes L. (2013b). Aloevera and methylsulfonylmethane as dietary supplements: Their potential benefi ts for arthritic patients with diabetic complications.: 51-68.
    Search in Google Scholar
  13. Banasova M, Valachova K, Rychly J, Priesolova E, Nagy M, Juranek I, Soltes L. (2011). Scavenging and chain breaking activity of bucillamine on free-radical mediated degradation of high molar mass hyaluronan.: 205-206.
    Search in Google Scholar
  14. Baňasova M, Valachova K, Hrabarova E, Priesolova E, Nagy M, Juranek I, Šoltes L. (2011). Early stage of the acute phase of joint infl ammation.testing of bucillamine and its oxidized metabolite SA981 in the function of antioxidants. 16th Interdisciplinary Czech-Slovak Toxicological Conference in Prague.(2): 22.
    Search in Google Scholar
  15. Barrett J P, Siviero P. (2002). Retrospective study of outcomes in Hyalgan(R)- treated patients with osteoarthritis of the knee.: 87-97.
    Search in Google Scholar
  16. Bergeret-Galley C, Latouche X, Illouz Y G.(2001). The value of a new fi ller material in corrective and cosmetic surgery: DermaLive and DermaDeep.: 249-255. 0 60 120 180 240 300 7 8 9 10Time [min]0 60 120 .
    Search in Google Scholar
  17. Betts WH, Cleland LG. (1982): Eff ect of metal chelators and antiinfl ammatory drugs on the degradation of hyaluronic acid.: 1469-1476.
    Open DOISearch in Google Scholar
  18. Blake DR, Hall ND, Treby DA. (1981). Protection against superoxide and hydrogen peroxide in synovial fl uid from rheumatoid patients.: 483-486.
    Search in Google Scholar
  19. Blewis ME, Nugent-Derfus GE, Schmidt TA, Schumacher BL, Sah RL. (2007). A model of synovial fl uid lubricant composition in normal and injured.: 26-39.
    Search in Google Scholar
  20. Bothner H, Wik O. (1987). Rheology of hyaluronate.: 25-30.
    Search in Google Scholar
  21. Brandt K. (1970). Modifi cation of chemotaxis by synovial fl uid hyaluronate.: 308-309.
    Search in Google Scholar
  22. Brown MB, Jones SA. (2005). Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.: 308-318.
    Search in Google Scholar
  23. Brown TJ, Laurent UBG, Fraser JRE. (1991). Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joints of the rabbit.: 125-34.
    Search in Google Scholar
  24. Bucolo C, Mangiafi co P. (1999). Pharmacological profi le of a new topical pilocarpine formulation.: 567-573.
    Search in Google Scholar
  25. Bucolo C, Spadaro A, Mangiafi co S. (1998). Pharmacological evaluation of a new timolol/pilocarpine formulation.: 101-106.
    Search in Google Scholar
  26. Camber O, Edman P, Gurny R. (1987). Infl uence of sodium hyaluronate on the meiotic eff ect of pilocarpine in rabbits.: 779-784.
    Search in Google Scholar
  27. Camber O, Edman P. (1989). Sodium hyaluronate as an ophthalmic vehicle - some factors governing its eff ect on the ocular absorption of pilocarpine.: 563-567.
    Search in Google Scholar
  28. Cantor JO, Cerreta JM, Armand G, Turino GM. (1998). Aerosolized hyaluronic acid decreases alveolar injury induced by human neutrophil elastase: 471-475.
    Search in Google Scholar
  29. Chabrecek P, Soltes L, Kallay Z, Fugedi A. (1990). Isolation and characterization of high molecular weight (3H) hyaluronic acid.: 1121-1125.
    Search in Google Scholar
  30. Chabrecek P, Soltes L, Kallay Z, Novak I. (1990). Gel permeation chromatographic characterization of sodium hyaluronate and its reactions prepared by ultrasonic degradation.: 201-204.
    Search in Google Scholar
  31. Chen FH, Rousche KT, Tuan RS. (2006). Technology Insight: adult stem cells in cartilage regeneration and tissue engineering.(7): 373-82.
    Search in Google Scholar
  32. Coleman P, Kavanagh E, Mason RM, Levick JR, Ashhurst DE. (1998). The proteoglycans and glycosaminoglycan chains of rabbit synovium.: 519-524.
    Search in Google Scholar
  33. Comper WD, Laurent TC. (1978). Physiological function of connective tissue polysaccharidcs.: 255-315.
    Search in Google Scholar
  34. Cowman MK, Matsuoka S. (2005). Experimental ap proaches to hyaluronan structure.: 791-809.
    Search in Google Scholar
  35. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. (1985). Concentration and molecular weight of sodium hyaluronate in synovial fl uid from patients with rheumatoid arthritis and other arthropathies.: 817-822.
    Search in Google Scholar
  36. Dobbie JW, Hind C, Meijers P, Bodart C, Tasiaux N, Perret J, Anderson JD. (1995). Lamellar body secretion: ultrastructural analysis of an unexplored function of synoviocytes.: 13-23.
    Search in Google Scholar
  37. Dougados M. (2000). Sodium hyaluronate therapy in osteoarthritis: arguments for a potential benefi cial structural eff ect.: 19-25.
    Search in Google Scholar
  38. Drafi F, Valachova K, Hrabarova E, Juranek I, Bauerova K, Šoltes L. (2010). Study of methotrexate and β-alanyl-L-histidine in comparison with L-glutathione on high-molar-mass hyaluronan degradation induced by ascorbate plus Cu (II) ions via rotational viscometry. 60th Pharmacological Days in Hradec Kralove.(3): 170.
    Search in Google Scholar
  39. Drobnik J. (1991). Hyaluronan in drug delivery.: 295-308.
    Search in Google Scholar
  40. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. (1998). Injectable hyaluronic acid gel for soft tissue augmentation - a clinical and histological study.: 1317-1325.
    Search in Google Scholar
  41. Edwards JCW, Wilkinson LS, Jones HM. (1994). The formation of human synovial cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion.: 355-67.
    Search in Google Scholar
  42. Edwards JCW (1995). Consensus statement. Second international meeting on synovium. Cell biology, physiology and pathology.: 389-91.
    Search in Google Scholar
  43. Eliaz RE, Szoka FC. (2001). Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.: 2592-2601.
    Search in Google Scholar
  44. Figueiredo F, Jones GM, Thouas GA, Trounson AO. (2002). The eff ect of extracellular matrix molecules on mouse preimplantation embryo development.: 443-451.
    Search in Google Scholar
  45. Fisher AE, Naughton ODP. (2005). Therapeutic chelators for the twenty fi rst century: new treatments for iron and copper mediated infl ammatory and neurological disorders.: 261-268.
    Search in Google Scholar
  46. Fraser JRE, Foo WK, Maritz JS. (1972). Viscous interactions of hyaluronic acid with some proteins and neutral saccharides.: 513-20.
    Search in Google Scholar
  47. Fraser JRE, Kimpton WG, Pierscionek BK, Cahill RNP. (1993). The kinetics of hyaluronan in normal and acutely infl amed synovial joints - observations with experimental arthritis in sheep.: 9-17.
    Search in Google Scholar
  48. Furnus CC, de Matos DG, Martinez AG. (1998). Eff ect of hyaluronic acid on development ofproduced bovine embryos.: 1489-99.
    Search in Google Scholar
  49. Gandolfi SA, Massari A, Orsoni JG. (1992). Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers.: 20-23.
    Search in Google Scholar
  50. Gardner DK, Lane M, Stevens J, Schoolcraft WB. (2003). Changing the start temperature and cooling rate in a slow-freezing protocol increases human blastocyst viability.: 407-410.
    Search in Google Scholar
  51. Gardner DK, Rodriegez-Martinez H, Lane M. (1999). Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer.: 2575-2580.
    Search in Google Scholar
  52. Ghosh P, Guidolin D. (2002). Potential mechanism of action of intraarticular hyaluronan therapy in osteoarthritis: are the eff ects molecular weight dependent?: 10-37.
    Open DOISearch in Google Scholar
  53. Ghosh S, Jassal M. (2002). Use of polysaccharide fi bres for modem wound dressings. Indian: 434-450.
    Search in Google Scholar
  54. Gibbs DA, Merrill EW, Smith KA, Balazs EA. (1968). Rheology of hyaluronic acid.: 777-91.
    Search in Google Scholar
  55. Glogau RG. (2000). The risk of progression to invasive disease.: S23-S24.
    Search in Google Scholar
  56. Grootveld M, Henderson EB, Farrell A, Blake DR, Parkes HG, Haycock P. (1991). Oxidative damage to hyaluronate and glucose in synovial fl uid during exercise of the infl amed rheumatoid joint. Detection of abnormal low-molecular- mass metabolites by proton-N.M.R. spectroscopy.: 459-467.
    Search in Google Scholar
  57. Guidolin DD, Ronchetti IP, Lini E. (2001). Morphological analysis of articular cartilage biopsies from a randomized. clinical study comparing the eff ects of 500-730 kDa sodium hyaluronate Hyalgan(R) and methylprednisolone acetate on primary osteoarthritis of the knee.: 371-381.
    Search in Google Scholar
  58. Gurny R, Ibrahim H, Aebi A. (1987). Design and evaluation of controlled release systems for the eye.: 367-373.
    Search in Google Scholar
  59. Haddad JJ, Harb HL. (2005). L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-infl ammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s).: 987-1014.
    Search in Google Scholar
  60. Hamburger MI, Lakhanpal S, Mooar PA, Oster D. (2003). Intra-articular hyaluronans: a review of product-specifi c safety profi les.: 296-309.
    Search in Google Scholar
  61. Haubeck HD, Kock R, Fischer DC, van de Leur E, Hoff meister K, Greiling H. (1995). Transforming growth factor s1, a major stimulator of hyaluronan synthesis in human synovial lining cells.: 669-677.
    Search in Google Scholar
  62. Herrero-Vanrell R, Fernandez-Carballido A, Frutos G, Cadorniga R. (2000). Enhancement of the mydriatic response to tropicamide by bioadhesive polymers.: 419-428.
    Search in Google Scholar
  63. Hills BA, Crawford RW. (2003) Normal and prosthetic synovial joints are lubricated by surface-active phospholipid: a hypothesis.: 499-505.
    Open DOISearch in Google Scholar
  64. Hlavacek M. (1993). The role of synovial fl uid fi ltration by cartilage in lubrication of synovial joints.(10): 1145-50.
    Search in Google Scholar
  65. Hochberg MC. (2000). Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee.: 2-10. Hrabarova E, Valachova K, Rapta P, Soltes L. (2010). An alternative standard for trolox-equivalent antioxidant-capacity estimation based on thiol antioxidants. Comparative 2,2’-azinobis[3-ethylbenzothiazoline-6-sulfonic acid] decolorization and rotational viscometry study regarding hyaluronan degradation.(9): 2191-2200.
    Open DOISearch in Google Scholar
  66. Hrabarova E, Valachova K, Rychly J, Rapta P, Sasinkova V, Malikova M, Soltes L. (2009). High-molar-mass hyaluronan degradation by Weissberger’s system: Pro- and anti-oxidative eff ects of some thiol compounds.: 1867-1875.
    Search in Google Scholar
  67. Hrabarova E, Valachova K, Juranek I, Soltes L. (2012). Free-radical degradation of high-molar-mass hyaluronan induced by ascorbate plus cupric ions: evaluation of antioxidative eff ect of cysteine-derived compounds.: 309-317.
    Search in Google Scholar
  68. Hrabarova E, Gemeiner P, Soltes L. (2007). Peroxynitrite:andsynthesis and oxidant degradative action on biological systems regarding biomolecular injury and infl ammatory processes.: 417-437.
    Search in Google Scholar
  69. Hrabarova E, Valachova K, Juranek I, Šoltes L. (2011).In: “Kinetics, Catalysis and Mechanism of Chemical Reactions” G. E. Zaikov (eds), Nova Science Publishers, New York, pp. 29-36.
    Search in Google Scholar
  70. Hrabarova E, Valachova K, Rychly J, Rapta P, Sasinkova V, Gemeiner P, Šoltes L. (2009). High-molar-mass hyaluronan degradation by the Weissberger´s system: pro- and antioxidative eff ects of some thiol compounds.1867-1875.
    Search in Google Scholar
  71. Hultberg M, Hultberg B. (2006). The eff ect of diff erent antioxidants on glutathione turnover in human cell lines and their interaction with hydrogen peroxide.(3): 192-198.
    Search in Google Scholar
  72. Hutadilok N. Ghosh P, Brooks PM. (1988). Binding of haptoglobin. inter-α- trypsin inhibitor, and l proteinase inhibitor to synovial fl uid hyaluronate and the infl uence of these proteins on its degradation byoxygen derived free radicals.: 377-85.
    Search in Google Scholar
  73. Inoue M, Katakami C. (1993). The eff ect of hyaluronic-acid on corneal epithelial- cell proliferation.: 2313-2315.
    Search in Google Scholar
  74. Itano N, Kimata K. (2002). Mammalian hyaluronan synthases: 195-199.
    Search in Google Scholar
  75. Jaakma U, Zhang B R, Larsson B. (1997). Eff ects of sperm treatments on thedevelopment of bovine oocytes in semidefi ned and defi ned media.: 711-720.
    Search in Google Scholar
  76. Jang G, Lee BC, Kang SK, Hwang WS. (2003). Eff ect of glycosaminoglycans on the preimplantation development of embryos derived fromfertilization and somatic cell nuclear transfer.: 179-185.
    Search in Google Scholar
  77. Jarvinen K, Jarvinen T, Urtti A. (1995). Ocular absorption following topical delivery.: 3-19.
    Search in Google Scholar
  78. Jay GD, Britt DE, Cha DJ. (2000). Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fi broblasts.: 594-600.
    Search in Google Scholar
  79. Joly T, Nibart M, Thibier M. (1992). Hyaluronic-acid as a substitute for proteins in the deep-freezing of embryos from mice and sheep - aninvestigation.: 473-480.
    Search in Google Scholar
  80. Juranek I, Soltes L. (2012).In: “Kinetics, Catalysis and Mechanism of Chemical Reactions: From Pure to Applied Science. Volume- Tomorrow and Perspectives” R.M. Islamova, S.V. Kolesov, G.E. Zaikov (eds), Nova Science Publishers, New York pp. 1-10
    Search in Google Scholar
  81. Kano K, Miyano T, Kato S. (1998). Eff ects of glycosaminoglycans on the development ofmatured and fertilized porcine oocytes to the blastocyst stage.: 1226-1232.
    Search in Google Scholar
  82. Kelly MA, Goldberg VM, Healy WL. (2003). Osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics.: 1064-1079.
    Search in Google Scholar
  83. Kemmann E. (1998). Creutzfeldt-Jakob disease (CJD) and assisted reproductive technology (ART) - quantifi cation of risks as part of informed consent.: 1777.
    Search in Google Scholar
  84. Kessler A, Biasibetti M, da Silva Melo DA, Wajner M, Dutra-Filho CS, de Souza Wyse AT, Wannmacher CMD. (2008). Antioxidant eff ect of cysteamine in brain cortex of young rats.: 737-44.
    Search in Google Scholar
  85. Kim A, Checkla DM, Dehazya P, Chen WL. (2003). Characterization of DNAhyaluronan matrix for sustained gene transfer.: 81-95.
    Search in Google Scholar
  86. Kirwan J. (2001). Is there a place for intra-articular hyaluronate in osteoarthritis of the knee?: 93-101.
    Open DOISearch in Google Scholar
  87. Knight AD, Levick JR. (1984). Morphometry of the ultrastructure of the bloodjoint barrier in the rabbit knee.: 271-288.
    Search in Google Scholar
  88. Kogan G. (2010).In: New Steps in Chemical and Biochemical Physics. ISBN: 97 8-1-61668-923 -0. pp. 121-133.
    Search in Google Scholar
  89. Kogan G, Soltes L, Stern R, Mendichi R. (2007a).- in: Handbook of Polymer Research: Monomers, Oligomers, Polymers and Composites. Pethrick R. A, Ballada A, Zaikov G. E. (eds.), Nova Science Publishers, New York, pp. 393-439.
    Search in Google Scholar
  90. Kogan G, Soltes L, Stern R, Gemeiner P. (2007). Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications.: 17-25.
    Search in Google Scholar
  91. Kreil G. (1995). Hyaluronidases-A group of neglected enzymes.: 1666-1669.
    Search in Google Scholar
  92. Lane M, Maybach JM, Hooper K. (2003). Cryo-survival and development of bovine blastocysts are enhanced by culture with recombinant albumin and hyaluronan.: 70-78.
    Search in Google Scholar
  93. Langer K, Mutschler E, Lambrecht G. (1997). Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery - Part III. Evaluation as drug delivery system for ophthalmic applications.: 219-231.
    Search in Google Scholar
  94. Lath D, Csomorova K, Kollarikova G, Stankovska M, Soltes L. (2005). Molar mass-intrinsic viscosity relationship of high-molar-mass yaluronans: Involvement of shear rate.: 291-293.
    Search in Google Scholar
  95. Laurent TC, Laurent UBG, Fraser JRE. (1996). The structure and function of hyaluronan: An over view.: A1-A7.
    Search in Google Scholar
  96. Laurent TC. (1989).In: Ciba Foundation Symposium.John Wiley and Sons, New York.: 1-298.
    Search in Google Scholar
  97. Laurent TC, Fraser JRE. (1992). Hyaluronan.: 2397-2404.
    Search in Google Scholar
  98. Laurent TC. Laurent UBG, Fraser JRE. (1995). Functions of hyaluronan.429-32.
    Search in Google Scholar
  99. Laurent TC, Ryan M, Pictruszkiewicz A. (1960). Fractionation of hyaluronic acid. The polydispersity of hyaluronic acid from the vitreous body.: 476-85.
    Search in Google Scholar
  100. Levick JR. (1994). An analysis of the interaction between interstitial plasma protein, interstitial fl ow, and fenestral fi ltration and its application to synovium.: 90-125.
    Search in Google Scholar
  101. Leyden J, Narins RS, Brandt F. (2003). A randomized, double-blind, multicenter comparison of the effi cacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds.: 588-595.
    Search in Google Scholar
  102. Lim ST, Forbes B, Berry DJ, Martin GP, Brown MB. (2002).evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.: 73-82.
    Search in Google Scholar
  103. Luo Y, Prestwich GD. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate.: 755-763.
    Search in Google Scholar
  104. Luo Y, Ziebell MR, Prestwich GD. (2000). A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.: 208-218.
    Search in Google Scholar
  105. Maheu E, Ayral X, Dougados M. (2002). A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan(R).: 804-813.
    Search in Google Scholar
  106. Manuskiatti W, Maibach HI. (1996). Hyaluronic acid and skin: wound healing and aging.: 539-544.
    Search in Google Scholar
  107. Mazzucco D, Scott R, Spector M. (2004). Composition of joint fl uid in patients undergoing total knee replacement and revision arthroplasty: correlation with fl ow properties.: 4433-4445.
    Search in Google Scholar
  108. McCord JM. (1974). Free radicals and infl ammation: protection of synovial fl uid by superoxide dismutase.: 529-531.
    Search in Google Scholar
  109. McDonald JN, Levick JR. (1988). Morphology of surface synoviocytes in situ at normal and raised joint pressure, studied by scanning electron microscopy.: 232-240.
    Search in Google Scholar
  110. McDonald JN, Leviek JR. (1995). Eff ect of intra-articular hyaluronan on pressure- fl ow relation across synovium in anaesthetized rabbits.(Pt.1): 179-93.
    Search in Google Scholar
  111. Mendichi R, Soltes L. (2002). Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fl uid: 115-116.
    Open DOISearch in Google Scholar
  112. Meyer K, Palmer JW. (1934). The polysaccharide of the vitreous humor.: 629-634. Miltner O, Schneider U, Siebert CH. (2002). Effi cacy of intraarticular hyaluronic acid in patients with osteoarthritis-a prospective clinical trial.: 680-686.
    Search in Google Scholar
  113. Miyano T, Hirooka RE, Kano K. (1994). Eff ects of hyaluronic-acid on the development of 1-cell and 2-cell porcine embryos to the blastocyst stage invitro.: 1299-1305.
    Search in Google Scholar
  114. Miyazaki M, Sato S, Yamaguchi T. (1983)., Japan Pharmacological Conference. Tokyo, April 4, 1983.
    Search in Google Scholar
  115. Miyazaki T, Miyauchi S, Nakamura T. (1996). The eff ect of sodium hyaluronate on the growth of rabbit cornea epithelial cells.: 409-415.
    Search in Google Scholar
  116. Momberger TS, Levick JR, Mason RM. (2005). Hyaluronan secretion by synoviocytes is mechanosensitive.: 510-519.
    Search in Google Scholar
  117. Moreira CA, Armstrong DK, Jelliff e RW. (1991). Sodium hyaluronate as a carrier for intravitreal gentamicin - an experimental study.: 45-49.
    Search in Google Scholar
  118. Moreira CA, Moreira AT, Armstrong DK. (1991).andstudies with sodium hyaluronate as a carrier for intraocular gentamicin.: 50-56.
    Search in Google Scholar
  119. Morimoto K, Metsugi K, Katsumata H. (2001). Eff ects of lowviscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats.: 365-371.
    Search in Google Scholar
  120. Morimoto K, Yamaguchi H, Iwakura Y. (1991). Eff ects of viscous hyaluronatesodium solutions on the nasal absorption of vasopressin and an analog.: 471-474.
    Search in Google Scholar
  121. Morris ER, Rees DA, Welsh EJ. (1980). Conformation and dynamic interactions in hyaluronate solutions.: 383-400.
    Search in Google Scholar
  122. Myint P. (1987). The reactivity of various free radicals with hyaluronic acid steady-state and pulse radiolysis studies.194-202.
    Search in Google Scholar
  123. Necas J, Bartosikova L, Brauner P, Kolar J. (2008). Hyaluronic acid (hyaluronan): a review.(8): 397-411.
    Search in Google Scholar
  124. Niwa Y, Sakane T, Shingu M, Yokoyama MM. (1983). Eff ect of stimulated neutrophils from the synovial fl uid of patients with rheumatoid arthritis on lymphocytes: a possible role of increased oxygen radicals generated by the neutrophils.: 228-240.
    Search in Google Scholar
  125. Noble PW. (2002). Hyaluronan and its catabolic products in tissue injury and repair.: 25-29.
    Search in Google Scholar
  126. Oates KMN, Krause WE, Colby RH. (2002). Using rheology to probe the mechanism of joint lubrication: polyelectrolyte/protein interactions in synovial fl uid.: 53-58.
    Search in Google Scholar
  127. Ogston AG, Stanier JE. (1953). The physiological function of hyaluronic acid in synovial fl uid viscous, elastic and lubricant properties.244-52.
    Search in Google Scholar
  128. Ortonne JP. (1996). A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers.: 75-81.
    Search in Google Scholar
  129. Orvisky E, Soltes L, Chabrecek P, Novak I, Kery V, Stancikova M, Vins I. (1992). The determination of hyaluronan molecular weight distribution by means of high perfeormance size exclusion chromatography.: 3203-3218.
    Search in Google Scholar
  130. Parsons BJ, Al-Assaf S, Navaratnam S, Phillips GO. (2002)., in: Kennedy JF, Phillips GO, Williams PA, Hascall VC (Eds.), Hyaluronan: Chemical, Biochemical and Biological Aspects, Woodhead, Publishing Ltd, Cambridge, MA, pp. 141-150.
    Open DOISearch in Google Scholar
  131. Peer D, Florentin A, Margalit R. (2003). Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes.: 76-82.
    Search in Google Scholar
  132. Peer D, Margalit R. (2000). Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modifi ed liposomes.: 185-190.
    Search in Google Scholar
  133. Poli A, Mason RM, Levick JR. (2004). Eff ects of Arg- Gly-Asp sequence peptide and hyperosmolarity on the permeability of interstitial matrix and fenestrated endothelium in joints.: 463-476.
    Search in Google Scholar
  134. Praest BM, Greiling H, Kock R. (1997). Eff ects of oxygen-derived free radicals on the molecular weight and the polydispersity of hyaluronan solutions.:153-157 .
    Search in Google Scholar
  135. Price FM, Levick JR, Mason RM. (1996). Glycosaminoglycan concentration in synovium and other tissues of rabbit knee in relation to synovial hydraulic resistance.: 803-820.
    Search in Google Scholar
  136. Prisell PT, Camber O, Hiselius J, Norstedt G. (1992). Evaluation of hyaluronan as a vehicle for peptide growth factors.: 51-56.
    Search in Google Scholar
  137. Radin EL, Swann DA, Weisser PA. (1970). Separation of a hyaluronate-frec lubricating fraction from synovial fl uid.377-8.
    Search in Google Scholar
  138. Rapta P, Valachova K, Gemeiner P, Soltes L. (2009). High-molar-mass hyaluronan behavior during testing its radical scavenging capacity in organic and aqueous media: Eff ects of the presence of Manganese (II) ions.: 162-169.
    Search in Google Scholar
  139. Rapta P, Valachova K, Gemeiner P, Šoltes L. (2009). High-molar-mass hyaluronan behavior during testing its antioxidant properties in organic and aqueous media: eff ects of the presence of Mn(II) ions.: 162-169.
    Search in Google Scholar
  140. Rapta P, Valachova K, Zalibera M, Šnirc V, Šoltes L. (2010).In Monomers, Oligomers, Polymers, Composites, and Nanocomposites, Ed: R. A. Pethrick P. Petkov, A. Zlatarov G. E.
    Search in Google Scholar
  141. Zaikov, S. K. Rakovsky, Nova Science Publishers, N.Y, Chapter 7, pp. 113-126.
    Search in Google Scholar
  142. Rees MD, Kennett EC, Whitelock JM, Davies MJ. (2008). Oxidative damage to extracellular matrix and its role in human pathologies.: 1973-2001.
    Search in Google Scholar
  143. Revell PA. (1989). Synovial lining cells.: 49-51.
    Search in Google Scholar
  144. Risberg B. (1997). Adhesions: preventive strategies.: 32-39.
    Search in Google Scholar
  145. Rittig M, Tittor F, Lutjen-Drecoll E, Mollenhauer J, Rauterberg J. (1992). Immunohistochemical study of extracellular material in the aged human synovial membrane.: 219-234.
    Search in Google Scholar
  146. Rychly J, Soltes L, Stankovska M, Janigova I, Csomorova K, Sasinkova V, Kogan G, Gemeiner P. (2006). Unexplored capabilities of chemiluminescence and thermoanalytical methods in characterization of intact and degraded hyaluronans.(12): 3174-3184.
    Search in Google Scholar
  147. Saettone MF, Giannaccini B, Chetoni P, et al. (1991). Evaluation of highmolecular- weight and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine.: 131-139.
    Search in Google Scholar
  148. Saettone MF, Monti D, Torracca MT, Chetoni P. (1994). Mucoadhesive ophthalmic vehicles - evaluation polymeric low-viscosity formulations.: 83-92.
    Search in Google Scholar
  149. Sakurai K, Miyazaki K, Kodera Y. (1997). Anti-infl ammatory activity of superoxide dismutase conjugated with sodium hyaluronate.: 723-728.
    Search in Google Scholar
  150. Sasaki H, Yamamura K, Nishida K. (1996). Delivery of drugs to the eye by topical application.: 583-620.
    Search in Google Scholar
  151. Sattar A, Kumar S, West DC. (1992). Does hyaluronan have a role in endothelial cell proliferation ofthe synovium.: 37-43.
    Search in Google Scholar
  152. Schartz RA. (1997). The actinic keratoses. A perspective and update.: 1009-1019.
    Search in Google Scholar
  153. Schiller J, Volpi N, Hrabarova E, Soltes L. (2011).In:Handbook of Biopolymers and Their ApplicationsS. Kalia and L. Averous (eds), Wiley & Scrivener Publishing, USA pp. 3-34.
    Search in Google Scholar
  154. Schmid T, Lindley K, Su J, Soloveychik V, Block J, Kuettner K, Schumacher B. (2001a). Superfi cial zone protein (SZP) is an abundant glycoprotein in human synovial fl uid and serum.: 82.
    Open DOISearch in Google Scholar
  155. Schmid T, Soloveychik V, Kuettner K, Schumacher B. (2001b). Superfi cial zone protein (SZP) from human cartilage has lubrication activity.: 178.
    Search in Google Scholar
  156. Schumacher BL, Block JA, Schmid TM, Aydelotte MB, Kuettner KE. (1994). A novel proteoglycan synthesized and secreted by chondrocytes of the superfi cial zone of articular cartilage.: 144-152.
    Search in Google Scholar
  157. Schumacher BL, Hughes CE, Kuettner KE, Caterson B, Aydelotte MB. (1999). Immunodetection and partial c DNA sequence of the proteoglycan, superfi cial zone protein, synthesized by cells lining synovial joints: 110-120.
    Search in Google Scholar
  158. Schumacher BL, Schmidt TA, Voegtline MS, Chen AC, Sah RL. (2005). Proteoglycan 4 (PRG4) synthesis and immunolocalization in bovine meniscus.: 562-568.
    Search in Google Scholar
  159. Schwarz IM, Hills BA. (1996). Synovial surfactant: lamellar bodies in type B synoviocytes and proteolipid in synovial fl uid and the articular lining.: 821-827.
    Search in Google Scholar
  160. Schwarz IM, Hills BA. (1998). Surface-active phospholipids as the lubricating component of lubricin.: 21-26.
    Search in Google Scholar
  161. Scott DL, Shipley M, Dawson A, Edwards S, Symmons DP, Woolf AD. (1998).
    Search in Google Scholar
  162. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical eff ectiveness.: 546-554. Scott JE, Cummings C, Brass A, Chen Y. (1991). Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowingelectron microscopy and computer simulation.: 600-705.
    Open DOISearch in Google Scholar
  163. Servaty R, Schiller J, Binder H, Arnold K. (2000). Hydration of polymeric components of the cartilage - An infrared spectroscopic study on hyaluronic acid and chondroitin sulfate.: 123-129.
    Search in Google Scholar
  164. Simkovic I, Hricovini M, Soltes L, Mendichi R, Cosentino C. (2000). Preparation of water soluble/insoluble derivatives of Hyaluronic acid by cross linking with epichlorohydrin in aqueous NaOH/NH4OH solution.: 9-14.
    Search in Google Scholar
  165. Simon A, Safran A, Revel A. (2003). Hyaluronic acid can successfully replace albumin as the sole macromolecule in a human embryo transfer medium.: 1434-1438.
    Search in Google Scholar
  166. Soldati D, Rahm F, Pasche P. (1999). Mucosal wound healing after nasal surgery. A controlled clinical trial on the effi cacy of hyaluronic acid containing cream.: 253-261.
    Search in Google Scholar
  167. Soloveva ME, Solovev VV, Faskhutdinova AA, Kudryavtsev AA, Akatov VS. (2007). Prooxidant and cytotoxic action of N-acetylcysteine and glutathione in combinations with vitamin B12b.: 40-49.
    Search in Google Scholar
  168. Soltes L, Kogan G. (2009).In: “Kinetics & Thermodynamics for Chemistry & Biochemistry: Vol. 2” E. M. Pearce, G. E. Zaikov, G. Kirshenbaum (eds), Nova Science Publishers, New York (181-199).
    Search in Google Scholar
  169. Soltes L, Mendichi R, Kogan G, Mach M. (2004). Associating Hyaluronan Derivatives: A Novel Horizon in Viscosupplementation of Osteoarthritic Joints.: 468-472.
    Search in Google Scholar
  170. Soltes L, Brezova V, Stankovska M, Kogan G, Gemeiner P. (2006a). Degradation of high-molecular-weight hyaluronan by hydrogen peroxide in the presence of cupric ions.: 639-644.
    Open DOISearch in Google Scholar
  171. Soltes L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J. (2006b) Degradative action of reactive oxygen species on hyaluronan.: 659-668.
    Open DOISearch in Google Scholar
  172. Soltes L, Stankovska M, Brezova V, Schiller J, Arnhold J, Kogan G, Gemeiner P. (2006c). Hyaluronan degradation by copper (II) chloride and ascorbate: rotational viscometric, EPR spin-trapping, and MALDI-TOF mass spectrometric investigations: 2826-2834.
    Open DOISearch in Google Scholar
  173. Soltes L, Stankovska M, Kogan G, Germeiner P, Stern R. (2005). Contribution of oxidative reductive reations to high molecular weight hyaluronan catabolism.: 1242-1245.
    Search in Google Scholar
  174. Soltes L, Valachova K, Mendichi R, Kogan G, Arnhold J, Gemeiner P. (2007). Solution properties of high-molar-mass hyaluronans: the biopolymer degradation by ascorbate.: 1071-1077.
    Search in Google Scholar
  175. Soltes L. (2010). Hyaluronan -In:New Steps in Chemical and Biochemical Physics. Pure and Applied ScienceE. M. Pearce, G. Kirshenbaum, G. E. Zaikov (eds), Nova Science Publishers, New York pp. 137-152.
    Search in Google Scholar
  176. Stankovska M, Arnhold J, Rychly J, Spalteholz H, Gemeiner P, Soltes L. (2007).screening of the action of non-steroidal anti-infl ammatory drugs on hypochlorous acid-induced hyaluronan degradation.: 644-652.
    Search in Google Scholar
  177. Stankovska M, Soltes L, Vikartovska A, Mendichi r, Lath D, Molnarova M, Gemeiner P. (2004). Study of hyaluronan degradation by means of rotational Viscometry: Contribution of the material of viscometer.: 348-352.
    Search in Google Scholar
  178. Stankovska M, Hrabarova E, Valachova K, Molnarova M, Gemeiner P, Soltes L. (2006). The degradative action of peroxynitrite on high-molecular-weight hyaluronan .(Suppl. 2): 31-34.
    Search in Google Scholar
  179. Stankovska M, Soltes L, Vikartovska A, Gemeiner P, Kogan G, Bakos D. (2005). Degradation of high-molecular-weight hyaluronan: a rotational viscometry study.(Suppl. 17): 149-152.
    Search in Google Scholar
  180. Stern R, Kogan G, Jedrzejas M. J, Soltes L. (2007). The many ways to cleave hyaluronan.: 537-557.
    Search in Google Scholar
  181. Stiebel-Kalish H, Gaton DD, Weinberger D. (1998). A comparison of the eff ect of hyaluronic acid versus gentamicin on corneal epithelial healing.: 829-833.
    Search in Google Scholar
  182. Suchanek E, Simunic V, Juretic D, Grizelj V. (1994). Follicular-fl uid contents of hyaluronic-acid, follicle-stimulating-hormone and steroids relative to the success offertilization of human oocytes.: 347-352.
    Search in Google Scholar
  183. Surendrakumar K, Martyn GP, Hodgers ECM. (2003). Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.: 385-394.
    Search in Google Scholar
  184. Surini S, Akiyama H, Morishita M. (2003). Polyion complex of chitosan and sodium hyaluronate as an implant device for insulin delivery.: 265-268.
    Search in Google Scholar
  185. Surovcikova L, Valachova K, Banasova M, Snirc V, Priesolova E, Nagy M, Juranek I, Soltes L. (2012). Free-radical degradation of high-molar-mass hyaluronan induced by ascorbate plus cupric ions: Testing of stobadine and its two derivatives in function as antioxidants.: 57-64.
    Search in Google Scholar
  186. Swann DA, Silver FH, Slayter HS, Staff ord W, Shore E. (1985). The molecular structure and lubricating activity of lubricin isolated from bovine and human synovial fl uids.: 195-201.
    Search in Google Scholar
  187. Takayama K, Hirata M, Machida Y. (1990). Eff ect of interpolymer complex-formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate.: 1993-1997.
    Search in Google Scholar
  188. Tani E, Katakami C, Negi A (2002). Eff ects of various eye drops on corneal wound healing after superfi cial keratectomy in rabbits.: 488-495.
    Search in Google Scholar
  189. Tascioglu F, Oner C. (2003). Effi cacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.: 112-117.
    Search in Google Scholar
  190. Thibodeau PA, Kocsis-Bedard S, Courteau J, Niyonsenga T, Paquette B. (2001).
    Search in Google Scholar
  191. Thiols can either enhance or suppress DNA damage induction by catecholestrogens.: 62-73.
    Open DOISearch in Google Scholar
  192. Turino GM, Cantor JO. (2003). Hyaluronan in respiratory injury and repair.: 1169-1175.
    Search in Google Scholar
  193. Uthman I, Raynauld JP, Haraoui B. (2003). Intra-articular therapy in osteoarthritis.: 449-453.
    Search in Google Scholar
  194. Valachova K, Vargova A, Rapta P, Hrabarova E, Drafi F, Bauerova K, Juranek I, Soltes L. (2011). Aurothiomalate as preventive and chain-breaking antioxidant in radical degradation of high-molar-mass hyaluronan.: 1274-1283.
    Search in Google Scholar
  195. Valachova K, Banasova M, Machova L, Juranek I, Bezek S, Soltes L. (2013b). Antioxidant activity of various hexahydropyridoindoles.: 15-32.
    Search in Google Scholar
  196. Valachova K, Hrabarova E, Priesolova E, Nagy M, Banasova M, Juranek I, Soltes L. (2011)Free-radical degradation of high-molecular-weight hyaluronan induced by ascorbate plus cupric ions. Testing of bucillamine and its SA981- metabolite as antioxidants.: 664-670.
    Search in Google Scholar
  197. Valachova K, Hrabarova E, Drafi F, Juranek I, Bauerova K, Priesolova E, Nagy M, Šoltes L. (2010a). Ascorbate and Cu(II) induced oxidative degradation of high-molar-mass hyaluronan. Pro- and antioxidative eff ects of some thiols.(2): 101-104.
    Search in Google Scholar
  198. Valachova K, Hrabarova E, Gemeiner P, Šoltes L. (2008). Study of pro- and anti-oxidative properties of d-penicillamine in a system comprising highmolar- mass hyaluronan, ascorbate, and cupric ions.: 697-701.
    Search in Google Scholar
  199. Valachova K, Hrabarova E, Juranek I, Šoltes L. (2011b). Radical degradation of high-molar-mass hyaluronan induced by Weissberger oxidative system.
    Search in Google Scholar
  200. Testing of thiol compounds in the function of antioxidants. 16th Interdisciplinary Slovak-Czech Toxicological Conference in Prague.(2): 65.
    Search in Google Scholar
  201. Valachova K, Kogan G, Gemeiner P, Šoltes L. (2008b). Hyaluronan degradation by ascorbate: Protective eff ects of manganese (II).(9-10): 473−483.
    Search in Google Scholar
  202. Valachova K, Kogan G, Gemeiner P, Šoltes L. (2009b).In: Progress in Chemistry and Biochemistry. Kinetics, Thermodynamics, Synthesis, Properties and Application, Nova Science Publishers, N.Y, Chapter 20, pp. 201-215.
    Search in Google Scholar
  203. Valachova K, Mendichi R, Šoltes L. (2010c).In: Monomers, Oligomers, Polymers, Composites, and Nanocomposites, Ed: R. A. Pethrick P. Petkov, A. Zlatarov G. E. Zaikov, S. K. Rakovsky, Nova Science Publishers, N.Y, Chapter 6, pp. 101-111.
    Search in Google Scholar
  204. Valachova K, Rapta P, Kogan G, Hrabarova E, Gemeiner P, Šoltes L. (2009a). Degradation of high-molar-mass hyaluronan by ascorbate plus cupric ions: eff ects of D-penicillamine addition.: 389-395.
    Open DOISearch in Google Scholar
  205. Valachova K, Rapta P, Slovakova M, Priesolova E, Nagy M, Mislovičova D, Drafi F, Bauerova K, Šoltes L. (2013a).. In: Advances in Kinetics and Mechanism of Chemical Reactions, G. E. Zaikov, A. J. M. Valente, A. L. Iordanskii (eds), Apple Academic Press, Waretown, NJ, USA, pp. 1-19. Valachova K, Šoltes L. (2010b).In: New Steps in Chemical and Biochemical Physics. Pure and Applied Science, Nova Science Publishers, Ed: E. M. Pearce, G. Kirshenbaum, G.E. Zaikov, Nova Science Publishers, N.Y, Chapter 10, pp. 153-160.
    Search in Google Scholar
  206. Valachova K, Vargova A, Rapta P, Hrabarova E, Drafi F, Bauerova K, Juranek I, Šoltes L. (2011a). Aurothiomalate in function of preventive and chainbreaking antioxidant at radical degradation of high-molar-mass hyaluronan.: 1274-1283.
    Search in Google Scholar
  207. Vanos HC, Drogendijk AC, Fetter WPF. (1991). The infl uence of contamination of culture-medium with hepatitis-B virus on the outcome offertilization pregnancies.: 152-159.
    Search in Google Scholar
  208. Vazquez JR, Short B, Findlow AH. (2003). Outcomes of hyaluronan therapy in diabetic foot wounds.: 123-127.
    Search in Google Scholar
  209. Weigel PH, Hascall VC, Tammi M. (1997). Hyaluronan synthases.: 13997-14000.
    Search in Google Scholar
  210. West DC, Hampson IN, Arnold F, Kumar S. (1985). Angiogenesis induced by degradation products of hyaluronic acid.: 1324-1326.
    Search in Google Scholar
  211. Wilkinson LS, Pitsillides AA, Worrall JG, Edwards JC. (1992). Light microscopic characterization of the fi broblastlike synovial intimal cell (synoviocyte).: 1179-1184.
    Search in Google Scholar
  212. Worrall JG, Bayliss MT, Edwards JC. (1991). Morphological localization of hyaluronan in normal and diseased synovium.: 1466-1472.
    Search in Google Scholar
  213. Worrall JG, Wilkinson LS, Bayliss MT, Edwards JC. (1994). Zonal distribution of chondroitin-4-sulphate/ dermatan sulphate and chondroitin-6-sulphate in normal and diseased human synovium.: 35-38.
    Search in Google Scholar
  214. Yerushalmi N, Arad A, Margalit R. (1994). Molecular and cellular studies of hyaluronic acid-modifi ed liposomes as bioadhesive carriers for topical drugdelivery in wound-healing.: 267-273.
    Search in Google Scholar
  215. Yerushalmi N, Margalit R. (1998). Hyaluronic acid-modifi ed bioadhesive liposomes as local drug depots: eff ects of cellular and fl uid dynamics on liposome retention at target sites.: 21-26.
    Search in Google Scholar
  216. Yun YH, Goetz DJ, Yellen P, Chen W. (2004). Hyaluronan microspheres for sustained gene delivery and site-specifi c targetting.: 147-157.
    Search in Google Scholar
  217. Zhu YX, Granick S. (2003). Biolubrication: hyaluronic acid and the infl uence on its interfacial viscosity of an antiinfl ammatory drug.: 973-976.
    Search in Google Scholar
DOI: https://doi.org/10.2478/intox-2013-0019 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Journal RSS Feed
Language: English
Page range: 111 - 125
Published on: Feb 27, 2014
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
synovial joint fluid,
hyaluronan,
antioxidant,
thiol compound
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2014 Tamer Mahmoud Tamer, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.

Volume 6 (2013): Issue 3 (September 2013)
Previous article
Next article